Back to Search Start Over

Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.

Authors :
Cooks T
Pateras IS
Jenkins LM
Patel KM
Robles AI
Morris J
Forshew T
Appella E
Gorgoulis VG
Harris CC
Source :
Nature communications [Nat Commun] 2018 Feb 22; Vol. 9 (1), pp. 771. Date of Electronic Publication: 2018 Feb 22.
Publication Year :
2018

Abstract

TP53 mutants (mutp53) are involved in the pathogenesis of most human cancers. Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor suppressor activity of the wild-type protein. Tumor-associated macrophages (TAMs), a hallmark of solid tumors, are typically correlated with poor prognosis. Here, we report a non-cell-autonomous mechanism, whereby human mutp53 cancer cells reprogram macrophages to a tumor supportive and anti-inflammatory state. The colon cancer cells harboring GOF mutp53 selectively shed miR-1246-enriched exosomes. Uptake of these exosomes by neighboring macrophages triggers their miR-1246-dependent reprogramming into a cancer-promoting state. Mutp53-reprogammed TAMs favor anti-inflammatory immunosuppression with increased activity of TGF-β. These findings, associated with poor survival in colon cancer patients, strongly support a microenvironmental GOF role for mutp53 in actively engaging the immune system to promote cancer progression and metastasis.

Details

Language :
English
ISSN :
2041-1723
Volume :
9
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
29472616
Full Text :
https://doi.org/10.1038/s41467-018-03224-w